Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement

Forensic Science International

Volumn 217, Issue 1-3, 2012, Pages 174-181

  Nakanishi, Keiko ^a   Miki, Akihiro ^a   Zaitsu, Kei ^a   Kamata, Hiroe ^a   Shima, Noriaki ^a   Kamata, Tooru ^a   Katagi, Munehiro ^a   Tatsuno, Michiaki ^a   Tsuchihashi, Hitoshi ^b   Suzuki, Koichi ^b  

^a Chuo ward   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Amphetamine type stimulants (ATS); Designer drug; Immunoassay; On site test; Phenethylamine; Screening

Indexed keywords

2 METHOXYMETHAMPHETAMINE; 3 METHOXYMETHAMPHETAMINE; 3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 4 METHOXYAMPHETAMINE; 4 METHOXYMETHAMPHETAMINE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; BENZPHETAMINE; BROLAMFETAMINE; CODEINE; DEXAMPHETAMINE; DIMETAMFETAMINE; EPHEDRINE; FENFLURAMINE; HYDROXYAMPHETAMINE; MEPHENTERMINE; METHAMPHETAMINE; METHYLEPHEDRINE; N ETHYLAMPHETAMINE; NOREPHEDRINE; NORSELEGILINE; PHENETHYLAMINE; PHENETHYLAMINE DERIVATIVE; PHENTERMINE; PHOLEDRINE; PSEUDOEPHEDRINE; SELEGILINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DRUG CROSS REACTIVITY; DRUG METABOLISM; DRUG SCREENING; FEMALE; HUMAN; IMMUNOASSAY; LAW ENFORCEMENT; MALE; PRIORITY JOURNAL; SCHOOL CHILD; URINALYSIS;

EID: 84858793508     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2011.11.003     Document Type: Article

References (35)

1. D. Hunt, S. Kuck, L. Truitt, Methamphetamine Use. Lessons Learned, Final Report to the National Institute of Justice, 2006. Available from: http://www.ncjrs.gov/pdffies1/nij/grants/209730.pdf.
2. United Nations Office on Drugs and Crime, World Drug Report 2010, United Nations Publication, New York, 2010.
3. National Police Agency of Japan, White Paper on Police, Tokyo, Japan, 2010.
4. United Nations Office on Drugs and Crime, Patterns and trends of amphetamine-type stimulants and other drugs in East and South-East Asia (and neighbouring regions) 2009 United Nations Publication, New York, 2009.
5. Flanagan R.J., Taylor A., Watson I.D., Whelpton R. Fundamentals of Analytical Toxicology 2007, John Wiley & Sons, West Sussex, UK, pp.309-337.
6. Hand C., Baldwin D. Immunoassays in. Clark's Analytical Forensic Toxicology 2008, 375-391. Pharmaceutical Press, London, UK. S. Jickells, A. Negrusz (Eds.).
7. Shima N., Kamata H.T., Katagi M., Tsuchihashi H. Urinary excretion of the main metabolites of methamphetamine, including p-hydroxymethamphetamine-sulfate and p-hydroxymethamphetamine-glucuronide, in humans and rats. Xenobiotica 2006, 36:259-267.
8. Shima N., Katagi M., Kamata H., Zaitsu K., Kamata T., Nishikawa M., Miki A., Tsuchihashi H., Sakuma T., Nemoto N. Urinary excretion of the main metabolites of 3,4-methylendioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats. Xenobiotica 2008, 38:314-324.
9. Katagi M., Nishioka H., Nakajima K., Tsuchihashi H. Analysis of abused drugs in human urine with commercial enzyme immunoassay reagents. Jpn. J. Toxicol. Environ. Health 1996, 42:159-166. (in Japanese).
10. Miki A., Katagi M., Tsuchihashi H. Application of EMIT d.a.u. for the semiquantitative screening of methamphetamine incorporated in hair. J. Anal. Toxicol. 2002, 26:274-279.
11. Nishikawa M., Nakajima K., Tatsuno M., Kasuya F., Igarashi K., Fukui M., Tsuchihashi H. The analysis of cocaine and its metabolites by liquid chromatography/atmospheric pressure chemical ionization-mass spectrometry (LC/APCI-MS). Forensic Sci. Int. 1994, 66:149-158.
12. Katagi M., Tsutsumi H., Tatsuno M., Kamata T., Nishioka H., Miki A., Nakajima K., Tsuchihashi H. Application of assay o platelet monoamine oxidase type-B (MAO-B) activity to the discrimination of selegiline use from methamphetamine abuse. J. Health Sci. 2003, 49:189-194.
13. Shima N., Tsutsumi H., Kamata T., Nishikawa M., Katagi M., Miki A., Tsuchihashi H. Direct determination of glucuronide and sulfate of p-hydroxymethamphetamine in methamphetamine users' urine. J. Chromatogr. B 2006, 830:64-70.
14. Shima N., Kamata H.T., Katagi M., Tsuchihashi H., Sakuma T., Nemoto N. Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine. J. Chromatogr. B 2007, 857:123-129.
15. Katagi M., Tatsuno M., Miki A., Nishikawa M., Tsuchihashi H. Discrimination of dimethylamphetamine and methamphetamine use: simultaneous determination of dimethylamphetamine-N-oxide and other metabolites in urine by high-performance liquid chromatography-electrospray ionization mass spectrometry. J. Anal. Toxicol. 2000, 24:345-358.
16. Katagi M., Nishioka H., Nakajima K., Tsuchihashi H., Fujima H., Wada H., Nakamura K., Makino K. Direct high-performance liquid chromatographic and high-performance liquid chromatographic-thermospray-mass spectrometric determination of enantiomers of methamphetamine and its main metabolites amphetamine and p-hydroxymethamphetamine in human urine. J. Chromatogr. B. 1996, 676:35-43.
17. Katagi M., Tsutsumi H., Miki A., Nakajima K., Tsuchihashi H. Analysis of Clandestine tablets of amphetamine and their related designer drugs encountered in recent Japan. Jpn. J. Forensic Toxicol. 2002, 20:303-319.
18. Kamata T., Katagi M., Kamata H.T., Miki A., Shima N., Zaitsu K., Nishikawa M., Tanaka E., Honda K., Tsuchihashi H. Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites. Drug Metab. Dispos. 2006, 34:281-287.
19. Kamata H.T., Shima N., Zaitsu K., Kamata T., Miki A., Nishikawa M., Katagi M., Tsuchihashi H. Metabolism of the recently encountered designer drug, methylone, in humans and rats. Xenobiotica 2006, 36:709-723.
20. Kamata T., Zaitsu K., Katagi M., Suga K., Shibayama T., Kumihashi M., Miyauchi H., Tsuchihashi H. Abstract of the 26th Annual Meeting of Japanese Association of Forensic Toxicology 2007, 46-47.
21. Zaitsu K., Katagi M., Kamata H., Kamata T., Shima N., Miki A., Iwamura T., Tsuchihashi H. Discrimination and identification of the six aromatic positional isomers of trimethoxyamphetamine (TMA) by gas chromatography-mass spectrometry (GC-MS). J. Mass Spectrom. 2008, 43:528-534.
22. Zaitsu K., Katagi M., Kamata T., Kamata H., Shima N., Tsuchihashi H., Hayashi T., Matoba R. Determination of a newly encountered designer drug " p-methoxyethylamphetamine" and its metabolites in human urine and blood. Forensic Sci. Int. 2008, 177:77-84.
23. Zaitsu K., Kamata H.T., Kamata T., Katagi M., Miki A., Tsuchihashi H. Abstract of the 11th Annual Meeting of Japanese Association of Forensic Science and Technology 2005, 72.
24. Zaitsu K., Katagi M., Kamata H.T., Miki A., Tsuchihashi H. Discrimination and identification of regioisomeric β-keto analogues of 3 4-methylenedioxyamphetamines by gas chromatography-mass spectrometry. Forensic Toxicol. 2008, 26:45-51.
25. Shulgin A., Shulgin A. PiHKAL A Chemical Love Story 1991, Transform Press, Berkeley, CA, 490-778.
26. Kamata T., Katagi M., Nakanishi K., Zaitsu K., Shima N., Kamata H., Miki A., Tsuchihashi H. Jpn. J. Forensic Sci. Technol. 2010, 15:15-23. (in Japanese).
27. Niwaguchi T., Inoue T., Suzuki S. The metabolism of 1-phenyl-2-(N-methyl-N-benzylamino)propane (benzphetamine) in vivo in the rat Xenobiotica 1982, 12:617-625.
28. Miki A., Katagi M., Tatsuno M., Nakajima K., Tsuchihashi H. Discrimination of dimethylamphetamine and methamphetamine use: Simultaneous determination of dimethylamphetamine-N-oxide and other metabolites in urine by high-performance liquid chromatography-electrospray ionization mass spectrometry. Jpn. J. Forensic Toxicol. 2001, 19:46-57.
29. Hayakawa K., Miyoshi Y., Kurimoto H., Matsushima Y., Takayama N., Tanaka S., Miyazaki M. Simultaneous determination of methamphetamine and its metabolites in the urine samples of abusers by high performance liquid chromatography with chemiluminescence detection. Biol. Pharm. Bull. 1993, 16:817-821.
30. Valentine J.L., Kearns G.L., Sparks C., Letzig L.G., Valntine C.R., Shappell S.A., Neri D.E., Dejohn C.A. GC-MS determination of amphetamine and methamphetamine in human urine for 12h following oral administration of dextromethamphetamine: lack of evidence supporting the established forensic guidelines for methamphetamine confirmation. J. Anal. Toxicol. 1995, 19:581-590.
31. Segura M., Ortuno J., Farre M., McLura J.A., Pujadas M., Pizarro N., Llebaria A., Joglar J., Roset P.N., Segura J., de la Torre R. 3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans. Chem. Res. Toxicol. 2001, 14:1203-1208.
32. Pirnay S.O., Abraham T.T., Lowe R.H., Huestis M.A. Selection and optimization of hydrolysis conditions for the quantification of urinary metabolites of MDMA. J. Anal. Toxicol. 2006, 30:563-569.
33. Spiehler V. Hair analysis by immunological methods from the beginning to 2000. Forensic Sci. Int. 2000, 107:249-259.
34. Zweig M.H., Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 1993, 39:561-577.
35. Spiehler V. Sensitivity, specificity, and predictive value in quality assurance. QA issues in Clinical Toxicology 1996, 1-16. AACC Press, Washington, DC. S.L. Welch (Ed.).